<DOC>
	<DOCNO>NCT02949778</DOCNO>
	<brief_summary>Double blind , randomize , control , phase IV intervention trial . Both group receive quadratus lumborum Block ( QL ) , use ropivacaine 3.75 mg/mL intervention group , sterile sodium chloride control group . The aim study investigate effect QL Block perioperative pain postbariatric abdominoplasty .</brief_summary>
	<brief_title>Quadratus Lumborum Block Abdominoplasty</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Ropivacaine</mesh_term>
	<criteria>American Society Anesthesiologists Physical Classification Status ( ASA ) III Age 18 64 Weight equal 60 kg Scheduled postbariatric surgery standard full abdominoplasty perform Dr Fr√∏yen Patient expect able cooperate treatment follow . Signed informed consent obtain document accord International Conference Harmonization ( ICH ) good clinical practice ( GCP ) , national/local regulation . A history anaphylactic shock Cardiovascular disease hypertension and/or hyperlipidemia Known allergy ropivacaine morphine A history chronic pain Psychiatric comorbidity Scheduled opioid pain medication neuroleptic drug Coagulation disorder treatment platelet inhibitor Pregnancy breastfeed Treatment class III antiarrhythmic , sertindole , ziprasidone , amisulpride , ceritinib , hydroxyzine , fluvoxamine Any medical contraindication study intervention attend anaesthetist surgeon ( specify screen form ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>